Reine Allan
Prime Medicine, Inc. · Chief Financial Officer
Reine Allan is listed in filings as Chief Financial Officer at Prime Medicine, Inc.. This profile follows SEC Form 4 activity through Feb 27, 2026, including purchase activity. Recent filings connect the profile to Prime Medicine, Inc. (PRME). The current snapshot covers public activity from Dec 9, 2024 to Feb 27, 2026. Reported amounts are shown as $510.0K to $2.7M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Current Price |
|---|---|---|---|---|
| Historical insider buys and sells before the latest disclosure date will appear here after more snapshots are available. | ||||